Pharmacokinetics and concentrations of ceftiofur sodium in body fluids and endometrium after repeated intramuscular injections in mares.

The article presents a study investigating the pharmacokinetics, or the movement of drugs within the body, of ceftiofur sodium in mares. The research particularly focused on the drug’s concentration in various body fluids and endometrial tissues after repeated intramuscular injections.

Methodology

• The study involved 5 healthy mares, all of which received 5 consecutive intramuscular injections of ceftiofur sodium. The dosage administered was 2 mg/kg of body weight at 12-hour intervals.
• The concentration of ceftiofur was measured at different intervals in various body fluids including serum, synovial fluid, peritoneal fluid, and urine. It was also measured in cerebrospinal fluid (CSF) and endometrial tissue after the fifth dose.
• Statistical analysis was conducted to determine mean elimination rate constant and elimination half-life.

Findings

• The calculation showed that the mean elimination rate constant of the drug was 0.354 +/- 0.101 h-1. This suggests how fast the drug is removed from the body.
• The mean elimination half-life was determined to be 2.49 +/- 0.49 hours. Half-life indicates the time taken for the drug’s concentration in the body to reduce by half.
• The average concentration of ceftiofur in serum peaked around 1 hour after each injection, reaching the highest at 5.09 micrograms/ml after the fifth dose. Similarly, high concentrations were recorded in synovial fluid (3.02 micrograms/ml) and peritoneal fluid (3.23 micrograms/ml).
• The mean urine concentration was higher, reaching 15.72 micrograms/ml after the fifth dose, indicating that the drug is majorly excreted through urine.
• Ceftiofur was not detected in the cerebrospinal fluid or endometrial tissue, implying that the drug may not cross the blood-brain barrier or reach the endometrial tissue in significant amounts.
• Importantly, none of the mares exhibited adverse reactions to the drug, indicating its safety when administered in such a manner.

Implications

• This study provides valuable insight into the pharmacokinetics of ceftiofur sodium in mares. Understanding the drug distribution, absorption, metabolism, and excretion can help fine-tune the dosing regimen to maximize its therapeutic efficacy while minimizing possible side effects.
• The inability to detect ceftiofur in CSF and endometrial tissue may have implications for its use in treating infections in these areas.